Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

The Scotts Miracle-Gro Co (SMG.N)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2021-08-20	157.38	217.00	Buy
2021-10-04	146.25	196.00	Buy
2021-11-03	162.76	203.00	Buy
2022-01-04	160.00	189.00	Buy
2022-02-01	146.69	186.00	Buy
2022-04-19	117.61	152.00	Buy
2022-05-04	116.57	137.00	Buy
2022-06-07	102.18	125.00	Buy
2022-07-22	84.20	92.00	Neutral
2022-08-03	82.15	86.00	Neutral
2022-11-03	50.47	49.00	Neutral
2023-02-02	83.92	87.00	Neutral
2023-04-05	71.60	80.00	Neutral
2023-05-04	64.04	70.00	Neutral
2023-06-14	63.11	68.00	Neutral
2023-08-02	57.86	62.00	Neutral
2023-10-11	48.64	51.00	Neutral
2023-11-01	52.68	55.00	Neutral
2024-01-15	58.95	66.00	Neutral
2024-02-08	57.66	63.00	Neutral
2024-04-04	74.06	79.00	Neutral
2024-05-02	68.67	74.00	Neutral
2024-07-12	63.55	67.00	Neutral
2024-08-01	75.22	80.00	Neutral
2024-10-07	84.07	90.00	Neutral
2024-11-06	74.29	77.00	Neutral

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS may not be able to trade or custody the CRB securities referenced in this report in every jurisdiction.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.